Search

Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.

CMSC Abstracts Search Form (Titles and Authors only)

Search Accepted Abstracts
Sending

Search Results

Year ID Type Category Title Authors
2021 MDC11 Poster Multidisciplinary Care

Association between Patient Reported Outcomes and Gait in People with Multiple Sclerosis with Differing Disabilities

Christina Burke, PT, DPT1,2, Olivia Kaczmarek, BS3, MaryJo Kaleda, PT, DPT1, Elizabeth Casparian, SPT1, James Forbes, SPT1, Jillian Gallindo, SPT1, Morgan Staten, SPT1, Jared Srinivasan, BA3 and Mark Gudesblatt, MD4, (1)Stony Brook University, Stony Brook, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)South Shore Neurologic Associates, Patchogue, NY, (4)South Shore Neurologic Associates, P.C., Islip, NY

2021 MOC01 Poster Methods of Care

Impact of the COVID-19 Pandemic on People with Multiple Sclerosis: Results from an International Survey

Alana T Wong, PhD1, Svend S Geertsen, PhD1, Hubert van Hoogstraten, MD, PhD2, Bill Aschenbach, PhD, MBA1 and Jeffrey Chavin, MD, FAAN1, (1)Sanofi, Cambridge, MA, (2)Sanofi, Bridgewater, NJ

2021 MOC02 Poster Methods of Care

Psychoanalytic Telepsychology with MS Patients and Their Support People

Gayle R Lewis, Ph.D., MSCS, New York, NY

2021 MOC03 Poster Methods of Care

Floodlight MS: Using the Jobs-to-be-Done Framework to Identify Unmet Needs in Multiple Sclerosis Care to Support Digital Medical Device Development

Jorge Cancela, PhD, MBA, Roche, Basel, Switzerland, Cristina Costantino, PhD, Genentech, South San Francisco, CA and Jumaah Goldberg, DPT, Genentech, Inc., South San Francisco, CA

2021 MOC04 Poster Methods of Care

Floodlight MS: Utilizing Rapid Prototyping and Human Factors Studies to Develop a Digital Medical Device for Patient-Centric MS Care

Jorge Cancela, PhD, MBA1, Cristina Costantino, PhD2, Jumaah Goldberg, DPT3, Geraint Davies, BSc1 and JP Guyon, MS, MBA4, (1)Roche, Basel, Switzerland, (2)Genentech, South San Francisco, CA, (3)Genentech, Inc., South San Francisco, CA, (4)Roche, Belmont, CA

2021 MOC05 Poster Methods of Care

Improving Communication Gaps between Physicians Who Treat MS and the Health Insurance Community

Alexis Crispino, Director of Education & Healthcare Relations (MSAA South-Central), Multiple Sclerosis Association of America, Austin, TX and Kyle E Pinion, Senior Director of Education, Healthcare Relations & Advocacy, Education and Healthcare Relations, Multiple Sclerosis Association of America, Cherry Hill, NJ

2021 MOC06 Poster Methods of Care

Remote Monitoring in MS – Initial Experience with Medical Device Icompanion

Lars Costers, PhD1,2, Annabel Descamps, MSc1, Steve De Backer, PhD1, Guy Nagels, MD PhD1,2,3,4, Wim Van Hecke, PhD1 and Dirk Smeets, PhD1,2, (1)icometrix, Leuven, Belgium, (2)AIMS, Vrije Universiteit Brussel (VUB), Brussel, Belgium, (3)Neurology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussel, Belgium, (4)St. Edmund Hall, University of Oxford, Oxford, United Kingdom

2021 MOC07 Poster Methods of Care

Development and Implementation of a Psychoeducational Model for a Pediatric MS Clinic Transition Program

Yolanda S Wheeler, PhD, CRNP, CPNP-AC, MSCN, University of Alabama at Birmingham Center for Pediatric Onset Demyelinating Disease, Birmingham, AL; University of Alabama at Birmingham School of Nursing, Birmingham, AL and Evelyn Hunter, PhD, Department of Special Education, Rehabilitation and Counseling, Auburn University, Auburn, AL

2021 NDM01 Poster Neuroimmunology and disease models

Clinical and Diagnostic Spectrum of Optic Neuritis: A Single-Center Retrospective Study of Disorders Associated with Multiple Sclerosis, Aquaporin-4 Antibody, and Myelin Oligodendrocyte Glycoprotein Antibody

Dana Siegel, MD, Wayne State University, School of Medicine, detroit, MI, Meredith Van Harn, MPH, Neurology, Henry ford health system, Detroit, MI, Poonam Bansal, MD, Ophthalmology and Neurology, Henry Ford Health System, Detroit, MI, Mirela Cerghet, MD, PhD, Neurology, Henry Ford Hospital, Detroit, MI and Anza B Memon, MD, Neurology, Henry Ford Health System, Detroit, MI; Neurology, Wayne State University, School of Medicine, Detroit, MI

2021 NDM02 Poster Neuroimmunology and disease models

RGC-32 Contributes to Reactive Astrocytosis in Experimental Autoimmune Encephalomyelitis By Maintaining a Mature Phenotype

Austin J Beltrand, Medical Student, University of Maryland SOM, Baltimore, MD, Horea Rus, MD, PhD, Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD and Alexandru Tatomir, MD, Neurology, University of Maryland SOM, Baltimore, MD

2021 NDM03 Poster Neuroimmunology and disease models

Comparing Infection-Related Outcomes By Sex in Patients with Multiple Sclerosis and Matched Controls Using Administrative Claims Data

Riley Bove, MD1, Terra Slaton, MS2, Chris M. Kozma, PhD2, Amy L. Phillips, PharmD3, Danielle E. Harlow, PhD3 and Carroline Lobo, PhD3, (1)UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, (2)CK Consulting Associates, LLC, West Columbia, SC, (3)EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany

2021 NDM04 Poster Neuroimmunology and disease models

Effect of Ocrelizumab on Antibody Responses to EBV

Kaleigh E Olmsted, B.S., McGovern Medical School, Houston, TX and John W Lindsey, MD, Multiple Sclerosis And Neuroimmunology, McGovern Medical School, Houston, TX

2021 NDM05 Poster Neuroimmunology and disease models

Mucosal Associated Invariant T (MAIT) Cells Show Defective Activation in People with Multiple Sclerosis

Laura Ghezzi, MD1,2, Claudia Cantoni, PhD3, Daniela Galimberti, PhD2, Elio Scarpini, MD2, Anne Cross, MD1 and Laura Piccio, M.D., Ph.D1,4, (1)Neurology, Washington University in St. Louis, St. Louis, MO, (2)University of Milan, Milan, Italy, (3)Neurology, Washington University in St. Louis, St. louis, MO, (4)Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia

2021 NDM06 Poster Neuroimmunology and disease models

Phenotype and Functional Characterization of B-Cells, T-Cells and Monocytes Following Alemtuzumab Treatment in Patients with Multiple Sclerosis.

Nicole Kashani, M.D., Borna Vajdi, M.D., Lauren M Anderson, B.S., Gregory Baltayan, B.S., Eve E Kelland, Ph.D., Wendy Gilmore, Ph.D. and Brett T Lund, Ph.D., Neurology, University of Southern California, Los Angeles, CA

2021 NDM07 Poster Neuroimmunology and disease models

William Meador, MD, Neurology, UAB, Birmingham, AL and Chander Raman, PhD, Medicine, University of Alabama at Birmingham, Birmingham, AL

2021 NIB01 Poster Non-imaging Biomarkers
2021 NIB02 Poster Non-imaging Biomarkers
2021 NIB03 Poster Non-imaging Biomarkers

Combinatorial Analysis of Plasma and DNA Methylation Biomarkers in African American Patients with Multiple Sclerosis

Lindsay Clark, PhD1, Mark Band, PhD2, Jason P. Mendoza, PhD3, Linda Piccinini, PhD3 and Michael D Carrithers, MD, PhD4,5,6, (1)High Performance Biological Computing, Roy J. Carver Biotechnology Center, University of Illinois, Urbana, IL, (2)Functional Genomics, Roy J. Carver Biotechnology Center, University of Illinois, Urbana, IL, (3)Biogen, Cambridge, MA, (4)Neurology, University of Illinois College of Medicine, CHICAGO, IL, (5)Neurology, Jesse Brown Veterans Hospital, Chicago, IL, (6)Physiology and Biophysics, University of Illinois College of Medicine, Chicago, IL

2021 NIB04 Poster Non-imaging Biomarkers

Predicting Stress Levels and Response to a Self-Management Program Using Participant Demographic, Clinical, and Biomarker Data: A Secondary Analysis

Nico Osier, PhD, RN1,2, Alexa Stuifbergen, PhD, RN, FAAN1, Sawyer Stubbs, BS3 and Tapasvini Paralkar, BS3, (1)School of Nursing, The University of Texas at Austin, Austin, TX, (2)Neurology, Dell Medical School, Austin, TX, (3)University of Texas at Austin, Austin, TX

2021 NIB05 Poster Non-imaging Biomarkers

Non-Right-Handedness May be Associated with More Severe Multiple Sclerosis

Ruth E Propper, Ph.D.1, Melissa Villafana, B.A.1 and Glenn R Wylie, Ph.D.2, (1)Psychology, Montclair State University, Montclair, NJ, (2)Rocco Ortenzio Neuroimaging Center, Kessler Foundation, West Orange, NJ

2021 NIB06 Poster Non-imaging Biomarkers

Validating the Clinical Usefulness of the Timed 25-Foot Walk in MS in Routine Clinical Practice

Sage T Hewitt, B.S.1, Derrick Robertson, MD2, Angela Aungst, MPH3 and Christopher James, B.S.1, (1)USF Health Morsani College of Medicine, Tampa, FL, (2)College of Medicine, Neurology, University of South Florida, Tampa, FL, (3)Multiple Sclerosis Division Department of Neurology University of South Florida, Florida, FL

2021 NIB07 Poster Non-imaging Biomarkers

Cerebrospinal Fluid Protein Is Higher in Males with Multiple Sclerosis: Results from an International Multicenter Cohort

Sam I Hooshmand, DO1, Khalid El-Salem, MD2, Suha Agaileh, MD2 and Ahmed Z Obeidat, MD, PhD1, (1)Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Department of Neurosciences, Jordan University of Science and Technology, Irbid, Jordan

2021 NNN01 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Identifying Prospective Memory Deficits in MS with a Single Task from the Memory for Intentions Test: An IRT and ROC Analysis

Elizabeth S Gromisch, PhD1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7 and Sarah A Raskin, PhD8,9, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Neuroscience Program, Trinity College, Hartford, CT, (9)Department of Psychology, Trinity College, Hartford, CT

2021 NNN02 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Stability of the Gut Microbiota in Persons with Pediatric-Onset Multiple Sclerosis and Related Demyelinating Diseases

2021 NNN03 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Evaluation of Apathy in Multiple Sclerosis

Jeannie Lengenfelder, PhD1, Helen Genova, PhD1, Jacqueline Leddy, BA1, Brea Rivera, BS2 and Nancy D Chiaravalloti, PhD1, (1)Kessler Foundation, East Hanover, NJ, (2)Montclair State University, Montclair, NJ

2021 NNN04 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

FlywheelMS: Stratification of Anxiety and Depression By MS Subtype As Captured in Digitized Health Records

Kelly Zalocusky, PhD1, Ryan Gan, PhD, MPH1, Shemra Rizzo, PhD1, Katherine Belendiuk, PhD1, Laura Gaetano, PhD2, Jumaah Goldberg, DPT1, Nicole Bonine, PhD, MPH1, Gillian Hanson, ND3, Kieran Mace, PhD3 and Yifeng Jenny Chia, PhD1, (1)Genentech, Inc., South San Francisco, CA, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)PicnicHealth, San Francisco, CA

2021 NNN05 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Validation of Paced Auditory Serial Addition Test (PASAT) Regression Normative Data for Performance and Cognitive Fatigability in Multiple Sclerosis

Caitlin S Walker, H.BA., Carleton University, Ottawa, ON, Canada, Jason A Berard, PhD, Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada and Lisa A.S. Walker, Ph.D., The Ottawa Hospital Research Institute, Ottawa, ON, Canada

2021 NNN06 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Synesthesia May be Prevalent in Multiple Sclerosis

Melissa Villafana, B.A.1, Glenn R Wylie, Ph.D.2 and Ruth E Propper, Ph.D.1, (1)Psychology, Montclair State University, Montclair, NJ, (2)Rocco Ortenzio Neuroimaging Center, Kessler Foundation, West Orange, NJ

2021 NNN07 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Examining the Influence of Processing Speed on the Relation between Backward Walking and Falls in Persons with Multiple Sclerosis

Erin M Edwards, B.S.1, Ana M Daugherty, PhD2 and Nora E Fritz, PhD, PT, DPT, NCS1, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Psychology, Wayne State University, Detroit, MI

2021 NNN08 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Longitudinal Olfactory Patterns in Multiple Sclerosis: A Scoping Review and Implications for Use in Management of Disease

Lauren L Frederick, BS1, Ram Sivakumar, BS1, Sharon G Lynch, MD2 and Jennifer Villwock, MD3, (1)University of Kansas Medical Center, Kansas City, KS, (2)Neurology, University of Kansas Medical Center, Kansas City, KS, (3)Otolaryngology, University of Kansas Medical Center, Kansas City, KS

2021 NNN09 Poster Neurophysiology; Neuropsychology and Neuropsychiatry

Negative Dual Task Effects Can be Similar in People with Multiple Sclerosis and Controls, but Depend on Processing Time, Not Single Task Performance

Sheri L Bunyan, PhD, PT1,2 and Alexander V Ng, PhD2, (1)Physical Therapy, University of Wisconsin – Stevens Point, Stevens Point, WI, (2)Exercise Science, Marquette University, Milwaukee, WI

2021 NPP01 Poster Neuropathology and Pathogenesis

Oligoclonal Band Negative Multiple Sclerosis in Puerto Rico

2021 NPP02 Poster Neuropathology and Pathogenesis

Altered Expression of the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 (A1) Contributes to the Pathogenesis of Neurodegeneration in Multiple Sclerosis

Amber Anees, BSc., Health Sciences, University of Saskatchewan, Saskatoon, SK, Canada, Michael Levin, FRCPC, Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, Hannah E Salapa, PhD, Anatomy, Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada and Patricia Thibault, PhD, University of Saskatchewan, Saskatoon, SK, Canada

2021 PGM01 Poster Programs

The Influence of Tethered and Joint HCP and Patient Education on Clinical Practice Behavior, Patient Activation, and Empowerment

Carole Drexel, PhD1, Elizabeth L. del Nido, BA1, Scott D. Newsome, DO, MSCS, FAAN, FANA2, June Halper, MSN, APN-C, MSCN, FAAN3 and Wendy Turell, DrPH1, (1)PlatformQ Health Education, Needham, MA, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (3)Consortium of Multiple Sclerosis Centers, Hackensack, NJ

2021 PGM02 Poster Programs

Impact of a Virtual Wellness Program on Quality-of-Life Measures for Patients Living with MS during the COVID-19 Pandemic

Dina Jacobs, MD1, Nora Garland, MSW, LSW1, Vanessa Zimmerman, MSN, RN, MSCN1 and Sarah M Weinstein, MS2, (1)Neurology, University of Pennsylvania, Philadelphia, PA, (2)Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

2021 PGM03 Poster Programs

National MS Society Black MS Experience Summit, a Culturally Responsive Virtual Education Program for People Affected By MS

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Hooper K, Marshall J, Stewart K

2021 PGM04 Poster Programs

National MS Society Ask an MS Expert Offers Virtual Education Programing for People Affected By MS

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Liserio E, Tauchman J, Fiol J, Szafran E, Barnola A, Costello K

2021 PGM05 Poster Programs

National MS Society Facebook Community Offers Connection and Virtual Education Options for People Affected By MS

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Liserio E, Tauchman J, Herrmann B, Anzada P, Benson T, Gasper-Krueger A, Baker C, Cohrs R, Jensen A, Roper E, Ovsepian N

2021 PGM06 Poster Programs

Knowledge, Skills, and Confidence of Healthcare Professionals Participating in the Echo MS Program

Kevin N Alschuler, PhD1,2, Darren Ball, M.Ed.3, Annette Wundes, MD4, Salim Chahin, MD5, Mark Skeen, MD6 and Gloria von Geldern, MD4, (1)Department of Neurology, University of Washington School of Medicine, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)National Multiple Sclerosis Society, New York, NY, (4)Neurology, University of Washington, Seattle, WA, (5)Washington University in St. Louis, St. Louis, MO, (6)Neurology, Duke University, Durham, NC

2021 PGM07 Poster Programs

Improving MS Care through Educational Outreach to Generalists

Lynda R Hillman, DNP, MS Center of Excellence, West, VA Puget Sound Healthcare, Seattle, WA and Nancy Harris, MN, RN, VA-ECHO, VA Puget Sound Healthcare System, Seattle, WA